Our Investments

Investee Companies

Acorn Partners Limited

Product:
Life Sciences
Status:
Open
Sector:
Medical technologies
Aim of funding:
Seed
HMRC Advance Assurance received:
Yes

Deepbridge Capital LLP has seeded Acorn Partners Ltd, an efficient new way of originating, developing and delivering innovation within the broader healthcare space. In collaboration with our execution partners at WeAreNova and Europe’s largest children’s hospital Alder Hey, we redefine the... Read more

AlgaeCytes Limited

Product:
Technology Growth
Status:
Open
Sector:
Energy & Resource Innovation
Aim of funding:
Growth
HMRC Advance Assurance received:
Yes

Algaecytes Limited has developed a proven innovative approach to the production of Omega 3 fatty acids, which are polyunsaturated fatty acids used in numerous bodily functions, such as controlling blood clotting and building cell membranes in the brain. Associated with many health benefits,... Read more

arbnco Limited

Product:
Technology Growth
Status:
Open
Sector:
Real Estate Energy Efficiency
Aim of funding:
Growth
HMRC Advance Assurance received:
Yes

arbnco is a leading provider of commercial and portfolio real estate energy efficiency reporting and building risk mitigation solutions. The unique SaaS cloud based software solution, ‘arbn consult', focuses on commercial and portfolio real estate businesses, looking at both buildings’ energy... Read more

Aurio Limited

Product:
Life Sciences
Status:
Closed
Sector:
Tinnitus Technology
Aim of funding:
Seed
HMRC Advance Assurance received:
Yes

Aurio Limited has developed a patentable core technology that potentially eases the debilitating effects of tinnitus. 

Tinnitus is a perception of sound in the absence of an external source. Although it is often referred to as ‘ringing in the ears’, tinnitus can also be perceived as... Read more

Beamline Diagnostics Limited

Product:
Life Sciences
Status:
Open
Sector:
Cancer Diagnosis
Aim of funding:
Growth
HMRC Advance Assurance received:
Yes

BeamLine Diagnostics was set up to commercialise research in to the application of infrared spectroscopy to the diagnosis of cancer. Cancer is a worldwide problem with over 14 million new diagnoses and 8 million deaths recorded in 2012 alone (according to Cancer Research UK statistics, May 2015... Read more

CareCube Solutions Limited

Product:
Life Sciences
Status:
Closed
Sector:
Digital workflow
Aim of funding:
Seed
HMRC Advance Assurance received:
Yes

Care Cube Solutions Ltd (‘CCSL’) is a networked digital workflow system designed by cardiologists for users to simplify and centralise the complex tracking of patient flow in cardiology departments. In doing so, the technology seeks to safeguard patients from human error, and also assists... Read more

Cell Lane Ltd

Product:
Life Sciences
Status:
Closed
Sector:
Medicine
Aim of funding:
Seed
HMRC Advance Assurance received:
Yes

Cell Lane Ltd has been established to develop a cell isolation and separation platform technology, based on intellectual property assigned from the University of Leeds. This new technology seeks to assist in the future treatment of chronic diseases such as cancer and AIDS, and is intended to... Read more

Connect Childcare Group Limited

Product:
Technology Growth
Status:
Closed
Sector:
Nursery Management Software
Aim of funding:
Commercialisation
HMRC Advance Assurance received:
Yes

Since the commencement of its development activities in 2011, Connect Childcare has developed innovative nursery management software systems for the UK childcare sector, enabling childcare staff to spend more time with the children in their care whilst simultaneously bringing parents closer to... Read more

Elasmogen Limited

Product:
Life Sciences
Status:
Open
Sector:
Drug discovery
Aim of funding:
Growth
HMRC Advance Assurance received:
Yes

Elasmogen Ltd is a biologics company spun out of the University of Aberdeen in Feb 2016 and has developed a validated and IP-protected ‘soloMER’ platform. ‘soloMer’ refers to employ of small proteins as a site-specific drug delivery mechanism for ophthalmology and solid tumour cancers.

... Read more

EligoChem Limited

Product:
Life Sciences
Status:
Closed
Sector:
Drug design
Aim of funding:
Growth
HMRC Advance Assurance received:
Yes

EligoChem has developed a proprietary and patentable technology that facilitates the design of highly water-soluble drugs that are absorbed well by the human body.  One in fifteen known drug compounds have this combination of properties, but they are present in only one in ten thousand... Read more

eLucid mHealth Limited

Product:
Life Sciences
Status:
Closed
Sector:
Medical Technology
Aim of funding:
Growth
HMRC Advance Assurance received:
Yes

eLucid mHealth is a medication technology company creating proprietary, patented automatic adherence/compliance monitoring tools as part of an integrated healthcare system.

eLucid mHealth’s solutions and devices have been specifically designed with patient feedback; they are non-invasive... Read more

Fen EP Limited

Product:
Life Sciences
Status:
Closed
Sector:
Sudden Cardiac Death prevention
Aim of funding:
Seed
HMRC Advance Assurance received:
Yes

PEFA (‘paced electrogram fractionation analysis’) is a unique procedure and was invented by cardiologist Dr Richard Saumarez , initially when based at St Georges Hospital, London, and subsequently developed and tested at the University of Cambridge and Papworth Hospital.

The procedure that... Read more

Filisia Interfaces Limited

Product:
Life Sciences
Status:
Closed
Sector:
Training Technology
Aim of funding:
Seed
HMRC Advance Assurance received:
Yes

Filisia addresses the training, rehabilitation and access requirements of people with special education and rehabilitation needs through creative and connected technology.       

Filisia estimates that there are over 150 million people globally with... Read more

Glyconics Ltd

Product:
Life Sciences
Status:
Closed
Sector:
Diagnostcis
Aim of funding:
Seed
HMRC Advance Assurance received:
Yes

Glyconics Ltd is an innovative diagnostics company which has developed a novel approach to the diagnosis and monitoring of chronic and acute diseases including respiratory disease.  The new device uses fourier transform infrared spectroscopy (FITR) to analyse sputum (saliva) samples for... Read more

Ibis Vision Limited

Product:
Life Sciences
Status:
Closed
Sector:
Glaucoma Detection
Aim of funding:
Growth
HMRC Advance Assurance received:
Yes

Ibis Vision has developed ‘Ring of Sight’ (ROS), a unique eye test that is specifically designed for the early detection of glaucoma. Worldwide, glaucoma is the second most common cause of blindness and is caused by a build-up of pressure within the eye which in turn can damage the optic nerve... Read more

Inavya Ventures Ltd

Product:
Life Sciences
Status:
Closed
Sector:
Artificial Intelligence
Aim of funding:
Seed
HMRC Advance Assurance received:
Yes

Inavya Ventures Ltd’s intention is to create a Machine Learning & Artificial Intelligence mobile application aimed primarily at improving interactions within the global healthcare, retail, hospitality and financial markets. The product and services offering is trademarked and called ‘AVATR... Read more

Keia Ltd

Product:
Life Sciences
Status:
Closed
Sector:
Healthcare
Aim of funding:
Seed
HMRC Advance Assurance received:
Yes

Keia Ltd was founded to address the very fragmented global market in which a large number of wellness practitioners operate. Wellness practitioners or holistic health practitioners are professionals who provide holistic health-related services, including counsellors, doctors, nurse... Read more

Levitex Foams Ltd

Product:
Life Sciences
Status:
Closed
Sector:
Healthcare
Aim of funding:
Seed
HMRC Advance Assurance received:
Yes

Levitex Foams Ltd was founded to address an identified need in the healthcare market for quality therapeutic mattresses.  The company has developed a new Levitex foam product that directly addresses poor body alignment and posture, with a particular focus on those users that are bed-bound.... Read more

Liverpool ChiroChem Limited

Product:
Technology Growth
Status:
Open
Sector:
Pharmaceutical R&D
Aim of funding:
Growth
HMRC Advance Assurance received:
Yes

Liverpool ChiroChem (LCC) operates in the supply chain of pharmaceutical research and development (R&D), supplying specialist chemical Chiral building blocks that enable laboratory based researchers to discover and build new drug molecules.  Specialist Chiral building blocks, such as... Read more

Metix Limited

Product:
Technology Growth
Status:
Closed
Sector:
Medical Technology
Aim of funding:
Commercialisation
HMRC Advance Assurance received:
Yes

The Company has designed and developed a portable, multi-parameter, non-invasive, hand-held emergency vital signs monitor, called COREMED X.   COREMED X measures electrocardiogram, heart rate, respiration rate, peripheral capillary oxygen saturation, capnography, blood pressure and... Read more

New Path Molecular Research Limited

Product:
Life Sciences
Status:
Closed
Sector:
Molecule research
Aim of funding:
Seed
HMRC Advance Assurance received:
Yes

The Company was established in January 2015 by Professor Steven Ley at the University of Cambridge, following his observation that, due to industry developments such as the reduction in internal R&D spending and out-sourcing to low cost economies, access to the most creative and innovative... Read more

Nuchido Ltd

Product:
Life Sciences
Status:
Closed
Sector:
Cosmeceutical
Aim of funding:
Seed
HMRC Advance Assurance received:
Yes

Nuchido Ltd was established to address the growing consumer demand for cosmeceutical products. Cosmeceuticals are the combination of cosmetics and pharmaceuticals, and are cosmetic products with bioactive ingredients that are validated by the science community.  According to The Company’s... Read more

Pacla Medical Ltd

Product:
Life Sciences
Status:
Closed
Sector:
Healthcare
Aim of funding:
Seed
HMRC Advance Assurance received:
Yes

Pacla Medical Ltd is a health care device company developing a new generation robotic physiotherapy device (‘Robo-Physio’) to improve the symptoms of Multiple Sclerosis (MS), chronic back pain and other conditions. Current interventions for MS and back pain offer limited clinical benefits, with... Read more

Parkure Limited

Product:
Life Sciences
Status:
Closed
Sector:
Parkinsons Research
Aim of funding:
Seed
HMRC Advance Assurance received:
Yes

The Company’s primary intention is the discovery of drugs that can prevent or inhibit the progression of Parkinson’s disease (‘PD’), for which there is currently no cure. Parkure’s primary goal is to discover and co-develop drugs that stop the disease progression; the Company will also exploit... Read more

PeptigelDesign Limited

Product:
Life Sciences
Status:
Closed
Sector:
Hydrogel Production
Aim of funding:
Seed
HMRC Advance Assurance received:
Yes

PeptiGelDesign Limited provides formulated ready-to-use and easy-to-handle hydrogels for culture dishes, multi-well plates, or cell culture inserts, used in research laboratories. PeptigelDesign believe the research services market is large and growing, estimating it to be worth c.$20bn on a... Read more

Pronec Ltd

Product:
Life Sciences
Status:
Closed
Sector:
Healthcare
Aim of funding:
Seed
HMRC Advance Assurance received:
Yes

Pronec Ltd seeks to develop a new class of cancer therapy that causes tumours to simply die, using proprietary peptides. The Company has identified a lead candidate molecule that causes necrosis of a wide range of tumour cell lines in culture, but does not affect normal cell lines. Cancer cell... Read more

Purius Limited

Product:
Life Sciences
Status:
Closed
Sector:
Pharmaceuticals
Aim of funding:
Seed
HMRC Advance Assurance received:
Yes

The Company was established in 2016 to exploit opportunities within the pharmaceutical sector, specifically delivering a solution to reduce manufacturing costs and increase output. To do so, the Company has established a novel technological process called ‘zero step purification’. The... Read more

Renephra Limited

Product:
Life Sciences
Status:
Open
Sector:
Medical Technology
Aim of funding:
Growth
HMRC Advance Assurance received:
Yes

Renephra Ltd is a UK based medical device development company that has developed and patented a disruptive technology that addresses the significant ongoing medical problems associated with treatment resistance of fluid overload within the body. Health issues often associated with fluid... Read more

Resonant Software Incorporated

Product:
Technology Growth
Status:
Closed
Sector:
B2B Software
Aim of funding:
Growth
HMRC Advance Assurance received:
Yes

Resonant Software Inc. has created innovative software to address human-centric inefficient processes in an automated, adaptive and thus time and cost-saving way.  Despite multi-billion annual investments in information technology by the financial services industry, there remain critical... Read more

Sky Medical Technology Limited

Product:
Technology Growth
Status:
Closed
Sector:
Medical Technology
Aim of funding:
Growth
HMRC Advance Assurance received:
Yes

Sky Medical Technology Limited has developed the OnPulse(TM) technology platform, a technology which, at its core, has been proven to dramatically improve blood flow (both volume and velocity) and elevates oxygen levels in the blood. The results indicate that the platform can be used across... Read more

Stent Tek Limited

Product:
Life Sciences
Status:
Closed
Sector:
Catheter Technology
Aim of funding:
Growth
HMRC Advance Assurance received:
Yes

The Company is developing a novel catheter system that enables patients to receive haemodialysis (‘HD’) in an improved manner. Currently, patients receiving HD must undergo a surgical procedure to create a surgical connection between an artery and a vein, the vein then acts as a ‘vascular access... Read more

SurveyMe Limited

Product:
Technology Growth
Status:
Closed
Sector:
Customer Feedback Software
Aim of funding:
Growth
HMRC Advance Assurance received:
Yes

Delivered by a free mobile app, SurveyMe (www.survey-me. com) is a disruptive technology that enables businesses globally (irrespective of their size, sector or location) to quickly capture bespoke, real-time mobile consumer and employee feedback for business... Read more

T-EDTA Ltd

Product:
Life Sciences
Status:
Closed
Sector:
Healthcare
Aim of funding:
Seed
HMRC Advance Assurance received:
Yes

T-EDTA Limited was established to develop anti-biofilm technologies and infection control products. Anti-biofilm is used in advanced wound care products using the anti-biofilm agents tri sodium/tetra sodium EDTA (‘t-EDTA’). A biofilm is a group of microorganisms in which cells stick to... Read more

Tookie Ltd

Product:
Life Sciences
Status:
Closed
Sector:
Medical
Aim of funding:
Seed
HMRC Advance Assurance received:
Yes

Tookie Ltd has developed a portfolio of innovative products addressing the unmet needs of patients who have genuine medical problems surrounding the security of central venous catheters (‘CVC’).  The catheters are put in place to allow long-term medicine treatment for pain, infection, or... Read more

Transcriptogen Limited

Product:
Life Sciences
Status:
Closed
Sector:
Cancer Treatment
Aim of funding:
Seed
HMRC Advance Assurance received:
Yes

Transcriptogen Ltd has developed a new approach to the treatment of cancer.  The Company has developed a lead molecule, TSG1301, which has been shown to be highly effective at treating Breast and Pancreatic Cancer in human tumours that have been grafted onto mice. In addition, it appears to... Read more

Viscgo Limited

Product:
Life Sciences
Status:
Closed
Sector:
Medical measurement
Aim of funding:
Seed
HMRC Advance Assurance received:
Yes

Viscgo was founded in August 2015 by Dr Elizabeth Boaden and Mr Steven Bookbinder to solve the medical need for consistently and accurately measuring the viscosity of differing drinks and textured modified foods for those people being treated with differing levels of dysphagia (i.e. swallowing... Read more

VoxSmart Limited

Product:
Technology Growth
Status:
Open
Sector:
Mobile recording technology
Aim of funding:
Commercialisation
HMRC Advance Assurance received:
Yes

VoxSmart is an award-winning mobile recording provider, addressing the global financial services compliance challenges of enabling integrated mobility and social technology within heavily regulated industries.  Under UK FCA regulation, specifically COBS 11.8, all authorised and regulated... Read more

vTime Holdings Limited

Product:
Technology Growth
Status:
Open
Sector:
Virtual and Augmented Reality Software
Aim of funding:
Commercialisation
HMRC Advance Assurance received:
Yes

vTime Holdings Ltd is focused on developing and publishing virtual and augmented reality engagement software, which is platform-agnostic and for both consumer and commercial use. This engagement software is called ‘vTime’ and is currently available via Gear VR, Cardboard (on both iOS and Android... Read more

Zilico Limited

Product:
Technology Growth
Status:
Open
Sector:
Medical Technology
Aim of funding:
Commercialisation
HMRC Advance Assurance received:
Yes

Zilico Limited has developed an innovative and patented cancer diagnostic device technology that will improve and extend current cancer screening programmes by providing accurate and objective results real-time.

The Company’s device examines the electrical impedance properties of tissues... Read more